From the ∗School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
†INSERM U1148, LVTS, University Paris Diderot, Paris, France
‡MR Research Collaborations, Siemens Healthcare Limited, Frimley, United Kingdom
§National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
∥National Cancer Institute, Bethesda, MD
¶MR Research Collaborations, Siemens Healthcare Limited, Melbourne, Australia
#MR Application Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany.
Received for publication November 4, 2022; and accepted for publication, after revision, December 12, 2022.
Conflicts of interest and sources of funding: Omar Darwish is a PhD candidate, and their university tuitions fees are covered by Siemens Healthineers. Dr Radhouene Neji is an employee of Siemens Healthineers United Kingdom, Dr Daniel Stäb is an employee of Siemens Healthcare Australia, and Dr Peter Speier is an employee of Siemens Healthcare Germany. For the remaining authors, none were declared. Sources of funding: CRUK City of London Centre Award (C7893/A26233), CRUK (EDDCPGM/100001), Siemens Healthineers, ITMO Aviesan 2020 (DESP/PB n°241), National Institutes of Health intramural fund, and by US Agency for International Development (USAID) and National Academy of Sciences through Subaward 2000012771 (any opinions, findings, conclusions, or recommendations expressed are those of the authors alone, and do not necessarily reflect the views of USAID or National Academy of Sciences).
Correspondence to: Ahmed M. Gharib, MD, National Institutes of Health, Building 10, Room 1C334, Bethesda, MD 20892. E-mail: [email protected].
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).
